CIK 0001175151 · Non-accelerated filer<br>Smaller reporting company
Cytosorbents Corp
Sign in to watch- Ticker
- CTSO
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 980373793
- Phone
- 973-329-8885
- Business address
- 305 COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- MedaSorb Technologies CORP, GILDER ENTERPRISES INC
- Open-market buys, last 90 days
- $120,435
- in 4 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$120,435. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-12 | BATOR MICHAEL G. Director | Grant or award · Stock Option (right to buy) | +17,250 | 17,250 | ||
| 2020-12-31 | BLOCH KATHLEEN P. Chief Financial Officer | Option exercise | +7,857 | $5.60 | $44K | 333,013 |
| 2020-12-31 | BLOCH KATHLEEN P. Chief Financial Officer | Option exercise · Stock Option (right to buy) | −7,857 | 47,793 | ||
| 2020-11-10 | Kraus Al Director | Option exercise | +8,000 | $3.45 | $28K | 133,046 |
| 2020-11-10 | Kraus Al Director | Sale | −8,000 | $8.00 | $64K | 125,046 |
| 2020-11-10 | Kraus Al Director | Option exercise · Stock Option (right to buy) | −8,000 | 0 | ||
| 2020-08-18 | Jones Edward Raymond Director | Option exercise | +4,000 | $3.35 | $13K | 78,800 |
| 2020-08-18 | Jones Edward Raymond Director | Option exercise · Stock Option (right to buy) | −4,000 | 0 | ||
| 2020-07-31 | BLOCH KATHLEEN P. Chief Financial Officer | Option exercise | +10,000 | $5.60 | $56K | 325,156 |
| 2020-07-31 | BLOCH KATHLEEN P. Chief Financial Officer | Option exercise · Stock Option (right to buy) | +10,000 | 55,650 | ||
| 2020-05-05 | Capponi Vincent President and COO | Option exercise | +10,123 | $9.26 | $94K | 427,772 |
| 2020-05-05 | Capponi Vincent President and COO | Option exercise · Stock Option (right to buy) | −10,123 | 0 | ||
| 2020-05-05 | Chan Phillip P. Chief Executive Officer | Option exercise | +14,100 | $9.39 | $132K | 714,682 |
| 2020-05-05 | Chan Phillip P. Chief Executive Officer | Option exercise · Stock Option (right to buy) | −14,100 | 0 | ||
| 2020-04-27 | Capponi Vincent Chief Operating Officer | Option exercise | +10,000 | $2.88 | $29K | 427,649 |
| 2020-04-27 | Capponi Vincent Chief Operating Officer | Sale | −10,000 | $10.00 | $100K | 417,649 |
| 2020-04-27 | Capponi Vincent Chief Operating Officer | Option exercise · Stock Option (right to buy) | −10,000 | 20,000 | ||
| 2020-04-12 | Deliargyris Efthymios Chief Medical Officer | Grant or award | +140,000 | 140,000 | ||
| 2020-04-12 | Deliargyris Efthymios Chief Medical Officer | Grant or award · Stock Option (right to buy) | +85,500 | 85,500 | ||
| 2020-03-10 | Capponi Vincent Chief Operating Officer | Option exercise | +6,500 | $3.45 | $22K | 417,649 |
Page 11 of 39 · 774 trades